- Prophylaxis and/or treatment of venous thrombosis and its extension and pulmonary embolism.
- Prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement.
- Reduces the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction. ( Quinolones ).
|
|
|||
|
|




